Demecarium

Demecarium

SCHEMBL2253116

C1=CPCC1.CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-].[Br-]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Demecarium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ACHE known ✓ P22303 15/20 0.54
▸ BCHE P06276 4/20 0.54
▸ LMNA P02545 3/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ FAAH O00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demecarium SCHEMBL29425243 0.87 ACHE (0.70) ACHEBCHELMNAMEN1KMT2A
Demecarium SCHEMBL34283 0.87 ACHE (0.70) ACHEBCHELMNAMEN1KMT2A
Demecarium SCHEMBL61421 0.86 ACHE (0.69) ACHEBCHELMNAMEN1KMT2A
Demecarium SCHEMBL31649032 0.86 ACHE (0.69) ACHEBCHELMNAMEN1KMT2A
SCHEMBL12043598 0.73 ACHE (0.73) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL29618009 0.72 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL41128 0.72 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Demecarium SCHEMBL28300620 0.71 ACHE (0.46) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL8026154 0.70 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A
Neostigmine SCHEMBL34419 0.70 ACHE (1.00) ACHEBCHELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9180045-B2 Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device MATI THERAPEUTICS INC. (US) 2015-11-10 — — US disclosed
US-20110202020-A1 TREATMENT MEDIUM DELIVERY DEVICE AND METHODS FOR DELIVERY OF SUCH TREATMENT MEDIUMS TO THE EYE USING SUCH A DELIVERY DEVICE QLT INC. (CA) 2011-08-18 — — US disclosed
Send feedback